Last reviewed · How we verify

NCT04623138

A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

Completed Last updated 11 January 2022
What this trial tests

trial in Covid19 in 847 participants. Completed in 1 June 2021.

Timeline
4 November 2020
Primary endpoint
1 June 2021
1 June 2021

Quick facts

Lead sponsorEvidation Health
StatusCompleted
Study typeOBSERVATIONAL
Enrollment847
Start date4 November 2020
Primary completion1 June 2021
Estimated completion1 June 2021
Sites1 location across United States

Conditions studied

Sponsor

Evidation Health

Who can join

18 and older, any sex, with Covid19 or SARS-CoV Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, observational, exploratory study exploring the relationship between passively-collected data from wearable activity devices and SARS-CoV-2 infection

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other Evidation Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04623138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing